Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers

Abstract

In patients with compensated cirrhosis and large varices treated with β-blockers, an HVPG decrease ≥10% significantly reduces the risk of developing ascitic decompensation and other related complications such as refractory ascites or hepatorenal syndrome.